CAS 853029-57-9
:8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
Description:
8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione, with CAS number 853029-57-9, is a synthetic organic compound characterized by its complex structure, which includes a purine core modified with various functional groups. This compound features a bromine atom, a butynyl side chain, and a quinazoline moiety, contributing to its potential biological activity. It is typically a solid at room temperature and may exhibit solubility in organic solvents, depending on the specific conditions. The presence of the bromine atom and the quinazoline ring suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals targeting specific biological pathways. Its molecular structure indicates that it may interact with biological macromolecules, potentially influencing cellular processes. As with many synthetic compounds, safety and handling precautions are essential, and its stability under various conditions should be assessed for practical applications.
Formula:C20H17BrN6O2
InChI:InChI=1S/C20H17BrN6O2/c1-4-5-10-26-16-17(24-19(26)21)25(3)20(29)27(18(16)28)11-15-22-12(2)13-8-6-7-9-14(13)23-15/h6-9H,10-11H2,1-3H3
InChI key:InChIKey=RCZJXCXNYGHNSR-UHFFFAOYSA-N
SMILES:C(C#CC)N1C2=C(N(C)C(=O)N(CC3=NC4=C(C(C)=N3)C=CC=C4)C2=O)N=C1Br
Synonyms:- 1H-Purine-2,6-dione, 8-bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-
- 1H-Purine-2,6-dione, 8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-
- 1H-Purine-2,6-dione, 8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-
- 8-Bromo-7-(2-Butyn-A-Yl)-3,7-Dihydro-3-Methyl-1-[(4-Methyl-2-Quinazolinyl)Methyl]-1H-Purine-2,6-Dione
- 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
- 8-Bromo-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione
- 8-bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
- 1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-bromoxanthine
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 8 products.
1H-Purine-2,6-dione,8-bromo-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-
CAS:Formula:C20H17BrN6O2Purity:98%Color and Shape:SolidMolecular weight:453.29208-Bromo-7-But-2-Ynyl-3-Methyl-1-(4-Methyl-Quinazolin-2-ylMethyl)-3,7-Dihydro-Purine-2,6-Dione
CAS:8-Bromo-7-But-2-Ynyl-3-Methyl-1-(4-Methyl-Quinazolin-2-ylMethyl)-3,7-Dihydro-Purine-2,6-DionePurity:98%Molecular weight:453.29g/mol8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
CAS:<p>Applications 8-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione is an intermediate used to prepare selective inhibitors of dipeptidyl peptidase 4 (DPP4) for potential use in the treatment of type 2 diabetes.<br>References Sutton, J., et al.: Bioorg. Med. Chem. Lett., 22, 1464 (2012); Lai, Z., et al.: Eur. J. Med. Chem., 83, 547 (2014)<br></p>Formula:C20H17BrN6O2Color and Shape:NeatMolecular weight:453.298-Bromo-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1- [(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione
CAS:Controlled ProductIntermediate in the synthesis of linagliptinFormula:C20H17BrN6O2Purity:Min. 95%Color and Shape:PowderMolecular weight:453.29 g/mol8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
CAS:Purity:98%Molecular weight:453.2999878







